Alterations in the Distribution of Cholinesterase Molecular Forms in Maternal and Fetal Brain Following Diisopropyl Fluorophosphate Treatment of Pregnant Rats

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 1989 Mar 1

PMID 2725829

Citations 4

Authors

A Meneguz

G M Bisso

H Michalek

Affiliations

Soon will be listed here.

Abstract

Previous work in this laboratory showed that during intoxication of rats with diisopropyl fluorophosphate at day 20 of pregnancy the recovery of ChE activity was faster in fetal than in maternal brain. In the present study the differences between recovery rats in dam and fetus brain were evaluated in terms of molecular forms and spontaneous reactivation. Using ultracentrifugation on sucrose gradient two molecular forms of ChE, namely 10S (tetrameric globular G4 form) and 4S (monomeric G1 form) were detected both in maternal and fetal brain of untreated rats. The ratios 10S/4S were about 5.0 and 0.75 for dams and 20-day fetuses, respectively. DFP administration (1.1 mg/kg sc) inducing at 90 min an about 80% inhibition of ChE in maternal brain caused a shift in its 10S/4S ratio to 1.63, and to 0.53 in fetal brain (in which overall inhibition was about 70%). This means that 10S forms were preferentially inhibited by DFP both in maternal and fetal brain. After 24 and 48 hr there was a negligible recovery of overall ChE in maternal brain with no shift in the ratio. On the other hand, complete recovery of ChE in fetal brain within 48 hr was accompanied by almost total normalization of the 10S/4S ratio. Rapid recovery of fetal ChE appeared not to depend on hydrolysis of DFP-inhibited ChE. In fact, maternal and fetal DFP-inhibited enzyme preparations following the addition of oximes (pralidoxime or obidoxime) in vitro showed similar rates of reactivation. The overall data indicate considerable differences in recovery rate of molecular forms between dams and fetuses, but not in reactivation by dephosphorylation.

Citing Articles

Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period?.

Qiao D, Seidler F, Padilla S, Slotkin T Environ Health Perspect. 2002; 110(11):1097-103.

PMID: 12417480 PMC: 1241065. DOI: 10.1289/ehp.021101097.

In vivo and in vitro effects of diisopropyl fluorophosphate and paraoxon on individual molecular forms of rat brain acetylcholinesterase.

Volpe M, Bisso G, Michalek H Neurochem Res. 1990; 15(10):975-9.

PMID: 2077431 DOI: 10.1007/BF00965742.

Size and charge isomers of acetylcholinesterase in the cerebral cortex of young and aged rats.

Bisso G, Briancesco R, Michalek H Neurochem Res. 1991; 16(5):571-5.

PMID: 1754033 DOI: 10.1007/BF00974876.

Meneguz A, Bisso G, Michalek H Neurochem Res. 1992; 17(8):785-90.

PMID: 1641060 DOI: 10.1007/BF00969013.

References

Dunlop D, Bodony R, Lajtha A . RNA concentration and protein synthesis in rat brain during development. Brain Res. 1984; 294(1):148-51. DOI: 10.1016/0006-8993(84)91320-9. View

Sung S, Ruff B . Intracellular distribution of molecular forms of acetylcholinesterase in rat brain and changes after diisopropylfluorophosphate treatment. Neurochem Res. 1987; 12(1):15-9. DOI: 10.1007/BF00971358. View

Layer P, Alber R, Sporns O . Quantitative development and molecular forms of acetyl- and butyrylcholinesterase during morphogenesis and synaptogenesis of chick brain and retina. J Neurochem. 1987; 49(1):175-82. DOI: 10.1111/j.1471-4159.1987.tb03411.x. View

Shahbazian F, Jacobs M, Lajtha A . Rates of protein synthesis in brain and other organs. Int J Dev Neurosci. 1987; 5(1):39-42. DOI: 10.1016/0736-5748(87)90046-3. View

Muller F, Dumez Y, Massoulie J . Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain. Brain Res. 1985; 331(2):295-302. DOI: 10.1016/0006-8993(85)91555-0. View

Atack J, Perry E, Bonham J, Candy J, Perry R . Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system. J Neurochem. 1987; 48(6):1687-92. DOI: 10.1111/j.1471-4159.1987.tb05724.x. View

Rieger F, Faivre-Bauman A, Benda P, Vigny M . Molecular forms of acetylcholinesterase: their de novo synthesis in mouse neuroblastoma cells. J Neurochem. 1976; 27(5):1059-63. DOI: 10.1111/j.1471-4159.1976.tb00308.x. View

Bisso G, Meneguz A, Michalek H . Development factors affecting brain acetylcholinesterase inhibition and recovery in DFP-treated rats. Dev Neurosci. 1982; 5(5-6):508-19. DOI: 10.1159/000112712. View

Davis G, Agranoff B . Metabolic behavior of isozymes of acetylcholinesterase. Nature. 1968; 220(5164):277-80. DOI: 10.1038/220277a0. View

10.

Wade P, Timiras P . A regional study of the molecular forms of acetylcholinesterase in the brain of developing and adult rats. Dev Neurosci. 1980; 3(3):101-8. DOI: 10.1159/000112383. View

11.

Rieger F, Vigny M . Solubilization and physicochemical characterization of rat brain acetylcholinesterase: development and maturation of its molecular forms. J Neurochem. 1976; 27(1):121-9. DOI: 10.1111/j.1471-4159.1976.tb01553.x. View

12.

Michalek H, Pintor A, Fortuna S, Bisso G . Effects of diisopropylfluorophosphate on brain cholinergic systems of rats at early developmental stages. Fundam Appl Toxicol. 1985; 5(6 Pt 2):S204-12. DOI: 10.1016/0272-0590(85)90130-7. View

13.

Michalek H, Pintor A, Fortuna S, Bisso G . Brain acetylcholinesterase and its molecular forms in a precocial murid, Acomys cahirinus, and rat during post-natal development. Acta Biochim Pol. 1984; 31(1):149-60. View

14.

Sung S, Ruff B . Molecular forms of sucrose extractable and particulate acetylcholinesterase in the developing and adult rat brain. Neurochem Res. 1983; 8(3):303-11. DOI: 10.1007/BF00965720. View

15.

Michalek H, Meneguz A, Bisso G . Molecular forms of rat brain acetylcholinesterase in DFP intoxication and subsequent recovery. Neurobehav Toxicol Teratol. 1981; 3(3):303-12. View

16.

Bisso G, Diana G, Fortuna S, Meneguz A, Michalek H . Change in the distribution of acetylcholinesterase molecular forms in frontoparietal cortex of the rat following nucleus basalis lesions with kainic acid. Brain Res. 1988; 449(1-2):391-4. DOI: 10.1016/0006-8993(88)91061-x. View

17.

Brimijoin S, Rakonczay Z . Immunology and molecular biology of the cholinesterases: current results and prospects. Int Rev Neurobiol. 1986; 28:363-410. DOI: 10.1016/s0074-7742(08)60112-9. View

18.

Vigny M, Gisiger V, Massoulie J . "Nonspecific" cholinesterase and acetylcholinesterase in rat tissues: molecular forms, structural and catalytic properties, and significance of the two enzyme systems. Proc Natl Acad Sci U S A. 1978; 75(6):2588-92. PMC: 392607. DOI: 10.1073/pnas.75.6.2588. View

19.

Brimijoin S . Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog Neurobiol. 1983; 21(4):291-322. DOI: 10.1016/0301-0082(83)90015-1. View

20.

Massoulie J, Bon S . The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurosci. 1982; 5:57-106. DOI: 10.1146/annurev.ne.05.030182.000421. View